1. Health consequences of improving the content of ergothioneine in the food supply
   Robert B. Beelman et al, 2022, FEBS Letters CrossRef
2. Chapter 5 – “Parkinson's disease – A role of non-enzymatic posttranslational modifications in disease onset and progression?”
   Sebastian Schmidt et al, 2022, Molecular Aspects of Medicine CrossRef
3. Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?
   Alexander Leathem et al, 2022, IJMS CrossRef
4. Alterations in thiol redox state and lipid peroxidation in the brain areas of male mice during aging
   Konstantinos Grintzalis et al, 2022, Advances in Redox Research CrossRef
5. Vitamin D (VD3) Intensifies the Effects of Exercise and Prevents Alterations of Behavior, Brain Oxidative Stress, and Neuroinflammation, in Hemiparkinsonian Rats
   Roberta Oliveira da Costa et al, 2022, Neurochem Res CrossRef
6. Glutathione: pharmacological aspects and implications for clinical use
   Andrea Novelli et al, 2022, Geriatr Care CrossRef
7. The SH-SY5Y Human Cell Line: Hawthorne Berry (Crataegus spp.) Protects against 6-OHDA Induced Neurotoxicity In Vitro Model of Parkinson's Disease
   Yeşim YENİ et al, 2024, IGUSABDER CrossRef
8. Comprehensive Transcriptome Profiling of Antioxidant Activities by Glutathione in Human HepG2 Cells
   Yoshiaki Uchida et al, 2024, Molecules CrossRef
9. In Vivo Study of Moringa oleifera Seed Extracts as Potential Sources of Neuroprotection against Rotenone-Induced Neurotoxicity
   Chand Raza et al, 2024, Plants CrossRef
10. NaCTR: Natural product-derived compound-based drug discovery pipeline from traditional oriental medicine by search space reduction
    Seunghwan Jung et al, 2024, Computational and Structural Biotechnology Journal CrossRef